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Letters to the Editor 
Dear Editor 
Informed consent for bronchoscopy 
Bronchoscopy and pre-medication are rarely 
associated with undesidered side-effects, but they are 
not free of them. For this reason, the process of 
informed consent is an ethical, legal and medical 
necessity for endoscopists before performing endo- 
scopic examinations, and the patients are commonly 
requested to sign a written consent form before 
undergoing bronchoscopy. Unfortunately, such 
forms are not standardized in Italy, and every 
endoscopy centre utilizes its own form that is 
usually drawn up by physicians working in the 
centre. These forms are often inadequate, as they do 
not include several pieces of key information and do 
not fulfil many essential principles of good clinical 
practice. 
We report here a consent form we recently 
observed (Fig. 1). Neither explanations concerning 
the mode of endoscopic procedure, nor information 
about risks and complications are included. In place 
of them, the form reports the following words: ‘. . 
informed me of the nature and purpose of the 
procedure, as well as the anticipated benefits, possible 
complications from known and unknown causes, 
foreseeable and unforeseeable risks, . . .’ 
What are the complications from unknown causes 
and the unforeseeable risks of bronchoscopy? How 
can physicians disclose them to patients? 
This is an example of the confusion reigning 
among endoscopists. Many physicians see con- 
sent forms primarily as protecting facilities from 
liability, but a signed consent form, like the above- 
mentioned one, is conclusive merely as to the issue of 
consent and not the adequacy of disclosure. In fact, 
there is no rational relationship between the fact 
proved (that the consent form was signed) and the 
fact presumed (that the patient was adequately 
informed). 
It is known that the written consent form mainly 
serves as a defence against a charge of unauthorized 
treatment (i.e. battery) and not to a claim of inad- 
equate disclosure (i.e. negligence) (1). Notwithstand- 
ing this, correct consent forms are useful and 
important, as they can also be seen as part of the 
FOR B 
Patient’s name . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
1) I empower the physicians working in this 
department to carry-out all necessary diagnostic 
and therapeutic procedures. 
2) Doctor . . .._................... has exhaustively 
informed me of the natllre and purpose of the 
procedure, as well as the anticipated benefits, 
possible complications from known and 
unknown causes, foreseeable and unforeseeable 
risks, and possible alternatives to the 
procedure. All my questions have been 
answered exhaustively and satisfactorily. 
3) I am aware that the results of the diagnostic 
and/or therapeutic procedure are not 
warranted. 
4) After reading the present form, I consciously 
consent to undergo bronchoscopy. 
Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Fig I Consent form for bronchoscopy used in an Italian 
endoscopy centre. 
process of physicians educating patients about the 
proposed treatment (2). Obviously, information is 
propaedeutical to understanding, and understanding 
is propaedeutical to consent. 
Components of informed consent require that: (1) 
consent be voluntary; (2) the patient be sufficiently 
mentally capable to engage in rational decision- 
making; and (3) adequate information be conveyed. 
Controversies reflected in both medical and legal 
literature concern the definition of ‘adequate infor- 
mation’. It is widely accepted that an informed 
consent form for endoscopic investigations must 
inform patients of the nature, purpose, indications, 
contraindications, mode of procedure, risks and 
benefits of the investigation, as well as any alternative 
forms of diagnosis and/or treatment (3). Only after 
reading and understanding such information, can the 
patient consciously consent to undergo endoscopic 
investigation. 
We believe that the confusion concerning such an 
issue must be resolved. Chest physicians’ associations 
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should state appropriate guidelines for disclosing 
detailed information. 
L. TREVISANI, S. SARTORI AND V. ABBASCIANO 
Department of Internal Medicine, S. Anna Hospital, 
Ferrara, Italy 
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Dear Editor 
New human light on bovine TB in cattle and wildlife? 
Progress towards the eradication of tuberculosis in 
man and livestock is being hampered by problems of 
diagnosis and misunderstandings as to aetiology and 
pathogenesis. Consequently, a comparison between 
species may be fruitful. 
The difficulty of early and reliable diagnosis is a 
hindrance as regards both man and cattle (1,2). Skin 
tests for both species may mis-identify both false 
positive cases which do not have TB, and false 
negative cases which do have TB. The critical impor- 
tance of more sensitive, faster blood or DNA tests 
would hence lie in picking up ‘missed’ TB carriers 
more rapidly, allowing for earlier chemotherapy and 
regression to a non-infectious state in man, for 
removal from the herd in cattle, thus minimizing 
onward transmission to new hosts. This is of particu- 
lar importance in cattle TB eradication schemes, 
since the skin test is, in practice, only 80% sensitive. 
Elderly, much tested, dairy cows may be desensitized, 
particularly during pregnancy which alters the 
immune response. Three TB carriers missed in this 
way caused 18 herd breakdowns (3). 
During the late stages of cattle TB eradication, the 
number of false positive ‘reactors’ may reach 80% of 
cases so that actual TB carriers are much harder to 
pick up. Two in three ‘TB Reactor Herds’ in England 
and Ulster currently turn out not to have TB on 
culturing (4). This has two major implications for the 
TB eradication scheme. Farms are subject to 4 
months minimum herd movement restriction need- 
lessly, and this costly annoyance could be avoided by 
immediately repeatable blood tests such as gamma 
interferon. Perhaps even more importantly, this may 
be the explanation for the pivotal misunderstanding 
in the Ministry of Agriculture’s TB scheme. It is 
claimed that only cattle with visibly lesioned (VL) 
lungs are infectious so that cattle are of little signifi- 
cance in passing TB to either other cattle or badgers, 
and hence badger culling is justified (5). However, 
there seems to be confusion between the two in three 
non-visibly lesioned (NVL) herds which produce no 
TB cattle nor TB badgers, and a small but highly 
significant minority of early TB cases which have 
‘overt’ lesions but are nevertheless infectious. This 
would explain why NVL cases may simply be pre- 
clinical cases which in 7(X80% of cattle have been 
exposed to Mycobacterium bovis. Such cases would 
then be the ‘undisclosed’ source of clusters of con- 
tiguous herd breakdowns (6-9). Underestimation of 
these factors and longer test intervals has led to 
slippage in the removal of VL/NVL cattle and further 
evidence that the problem has been mis-tested cattle 
all along, with a spillover of TB to badgers (6,lO). 
M. HANCOX 
17 Nouncells Cross, 
Stroud, U.K. 
21 August 1995 
References 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Bothamley GH, Rudd R, Festenstein F, Ivanyi J. 
Clinical value of the measurement of Mycobacterium 
tuberculosis specific antibody in pulmonary tuberculo- 
sis. Thorax 1992; 47: 270-275. - 
Neil1 SD. Hanna J. Mackie DP. Brvson TGD. Isolation 
of Mycobacterium’bovis from the iespiratory tracts of 
skin test negative cattle. Veterinary Record 1992; 131: 
4547. 
Richards RA. Inquiry into Bovine TB in west Cornwall, 
Ministry of Agriculture, London, 1973. 
Meldrnm KC. Animal Health, Ministry of Agriculture, 
Fisheries and Food, London, 1993, - - 
Hancox M. Cattle TB: ‘VL’ Onen cases or ‘NVL’ 
non-infectious cases? Respir Med 1995; in press. 
Hancox M. Badgers and bovine TB, Animal Welfare 
1994: 3: 253-254. 
Clifton-Hadley RS, Wilesmith JW, Richards MS, 
Upton P, Johnston S. The occurrence of Mycobac- 
terium bovis infection in cattle in and around an area 
subject to extensive badger control. Epid Znfect 1995; 
114: 179-193. 
Wilesmith JW, Williams DR. Tuberculosis lesions in 
reactor cows. Veterinary Record 1986; 118: 51. 
Wilesmith JW, Williams DR. Observations on the inci- 
dence of herds with non-visible lesioned tuberculin test 
reactors in southwest England. Epidemiol Infect 1987; 
99: 173-178. 
MAFF Bovine TB in Badgers, 18th Report, Ministry of 
Agriculture, Fisheries and Food, London, 1995. 
